BOTHELL, Wash., Jan. 24, 2011 /PRNewswire/ -- Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has been awarded Airworthiness Release (AWR) from the U.S. Army's Research, Development, and Engineering Command for the Powerheart® AED G3 Pro® automated defibrillator. The certification indicates the Powerheart AED G3 Pro complies with U.S. Department of Defense medical device certification criteria and is tested for use in air, sea, and land operations.
The Army, in determining airworthiness for the Powerheart AED G3 Pro, commissioned the United States Army Aeromedical Research Laboratory (USAARL) to perform in-flight and laboratory assessments to assess performance under a variety of conditions. The Powerheart AED G3 Pro met the rigorous requirements to earn the certification, including testing for device usability, electrical safety, electromagnetic interference, extreme temperatures, vibration, exposure to dust and rain, altitude, rapid decompression, acceleration, and crash durability.
"We are proud our AEDs have earned this certification for use by the U.S. Army in operations, whether by air, land, or sea," said Dave Marver, Cardiac Science chief executive officer. "This clearance validates the performance of our AEDs in the most challenging environments and conditions."
The global military AED market is estimated to be $60 million, with half of that in the US.
About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.
|SOURCE Cardiac Science Corporation|
Copyright©2010 PR Newswire.
All rights reserved